Press release
Travel Vaccines Market 2022: Size, Share, Demand, Trends and Analysis by 2027
According to the latest report by IMARC Group, titled "Travel Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2027" the global travel vaccines market reached a value of US$ 3.2 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 6.6 Billion by 2027, exhibiting at a CAGR of 11.1% during 2022-2027.Travel vaccines, also known as travel immunizations, are shots that travelers receive before visiting certain parts of the world where there is a high risk of developing certain diseases. These vaccines introduce the disease-causing microbes into the bloodstream to help the human body produce antibodies that will fight off the same if the person is exposed to the disease again. These shots must be taken at least 4 to 6 weeks before traveling, as it gives enough time for the immunization to start working efficiently.
COVID-19 Impact:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Download Free Report Sample Brochure: https://www.imarcgroup.com/travel-vaccines-market/requestsample
Travel Vaccines Market Trends:
The market is primarily driven by the rising occurrence of infectious and travel-related diseases such as diphtheria, Japanese encephalitis, meningitis, and yellow fever. In addition, there has been significant growth in international tourism due to rapid globalization and reduced international airfares. As a result, the demand for travel vaccines has witnessed substantial growth across the globe. Besides this, combination vaccines are gaining popularity among travelers as they protect against multiple diseases and reduce the number of vaccines required, thereby contributing to the market growth. Moreover, travel vaccines have become an essential requirement in an international travelers list as governments of numerous countries have mandated that travelers should be vaccinated before visiting disease-prone regions. For instance, the National Health Service (NHS) is providing several free travel vaccines for diseases, such as cholera, polio, typhoid and hepatitis A, in the United Kingdom to reduce the risk of these diseases being spread across the country.
Competitive Landscape With Key Players:
The competitive landscape of the travel vaccines market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
• GlaxoSmithKline Pharmaceuticals Limited
• Sanofi Pasteur
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• ALK-Abelló A/S
• Bavarian Nordic A/S
• Crucell (Subsidiary of Johnson & Johnson)
• CSL Limited
• AstraZeneca PLC
• Altimmune, Inc.
• Abbott Laboratories
• Hoffmann-La Roche, Inc.
Key Market Segmentation:
The report has segmented the travel vaccines market on the basis of composition, disease and region.
Breakup by Composition:
• Mono Vaccines
• Combination Vaccines
Breakup by Disease:
• Hepatitis A
• DPT
• Yellow Fever
• Typhoid
• Hepatitis B
• Measles and Mumps
• Rabies
• Meningococcal
• Varicella
• Japanese Encephalitis
• Others
Breakup by Region:
• North America (United States, Canada)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Turkey, South Africa, Others)
Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=1155&flag=C
Key Highlights of the Report:
• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Travel Vaccines Market 2022: Size, Share, Demand, Trends and Analysis by 2027 here
News-ID: 2686128 • Views: …
More Releases from IMARC Group

GCC Pet Food Market Size is Expected to Reach USD 422.9 Million By 2033 | CAGR: …
GCC Pet Food Market Overview
Market Size in 2024: USD 266.2 Million
Market Size in 2033: USD 422.9 Million
Market Growth Rate 2025-2033: 5.3%
According to IMARC Group's latest research publication, "GCC Pet Food Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", the GCC pet food market size was valued at USD 266.2 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 422.9 Million by 2033, exhibiting a…

GCC Residential Real Estate Market Size to Worth USD 147.77 Billion by 2033 | Wi …
GCC Residential Real Estate Market Overview
Market Size in 2024: USD 73.31 Billion
Market Size in 2033: USD 147.77 Billion
Market Growth Rate 2025-2033: 7.50%
According to IMARC Group's latest research publication, "GCC Residential Real Estate Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", the GCC residential real estate market size was valued at USD 73.31 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 147.77 Billion by…

GCC Drones Market Size to Surpass USD 2,005.3 Million by 2033 | With a 13.3% CAG …
GCC Drones Market Overview
Market Size in 2024: USD 588.2 Million
Market Size in 2033: USD 2,005.3 Million
Market Growth Rate 2025-2033: 13.3%
According to IMARC Group's latest research publication, "GCC Drones Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The GCC drones market size was valued at USD 588.2 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 2,005.3 Million by 2033, exhibiting a growth rate of…

Medical Imaging Market to Surpass USD 70.8 Billion by 2033, at a CAGR of 5.03%
Market Overview:
The medical imaging market is experiencing rapid growth, driven by Growing Burden of Chronic and Age-Related Diseases, Expansion of Government-Funded Health Infrastructure and Technological Advancements in Imaging Modalities. According to IMARC Group's latest research publication, "Medical Imaging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The global medical imaging market size reached USD 44.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach…
More Releases for Vaccines
Vaccines Market: Information by Type (Monovalent Vaccines, Multivalent Vaccines) …
Till date, vaccines have majorly contributed to eradicating several severe diseases—smallpox and polio—from the face of the earth. During 1980–90, around millions of people died due to smallpox. Moreover, after the introduction of a worldwide End Polio Campaign, the number of polio cases has reduced to 407 in 2013 from 350,000 in 1988, the CDC.
Global vaccines market was valued at USD 30.2 billion in 2018 and is expected to…
Global Pet Vaccine Market By Type (Attenuated Live Vaccines, Conjugate Vaccines, …
The Global Pet Vaccine Market 2020 report implement in-depth research of the industry with a focus on the current market trends future prospects. The Global Pet Vaccine Market report aims to provide an overview of Pet Vaccine Market players with detailed market segmentation by product, application and geographical region. It also provides market share and size, revenue forecast, growth opportunity. The most recent trending report Worldwide Pet Vaccine Market Economy…
Animal Vaccines Market Report 2018: Segmentation by Product (Attenuated Vaccines …
Global Animal Vaccines market research report provides company profile for Merck & Co., Inc., Zoetis Inc., Ceva Sant Animale, Sanofi S.A., Romvac, Vaxxinova, Biovac, Merial, Anicon Labor GmbH, Nexvet, PHL Associates, Inc., Hygieia Biological Laboratories, Colorado Serum Company, Pfizer, Arko Laboratories, Ltd. Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in…
Vaccines & Vaccination Market Report 2018: Segmentation by Type (Subunit vaccine …
Global Vaccines & Vaccination market research report provides company profile for CSL, Emergent BioSolutions, GSK, Johnson & Johnson, Pfizer, Merck, Sanofi, Abbott, AstraZeneca, Bavarian Nordic, Novartis, Bharat Biotech, Bio-Med and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year…
Global Veterinary Vaccines Market, By Technology Type (Inactivated Vaccines, Tox …
Veterinary/Animal Vaccines – Ensure good health of human’s best friends
Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccines include those for rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. Economic losses due to death of livestock is significant as it impacts the supply of dairy products, meat,…
Global Veterinary Vaccines Market, By Technology Type (Inactivated Vaccines, Tox …
Veterinary/Animal Vaccines – Ensure good health of human’s best friends
Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccines include those for rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. Economic losses due to death of livestock is significant as it impacts the supply of dairy products, meat,…